TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24344708

Group type: EXPERIMENTAL
Intervention: Hypnosis group (self-hypnosis training)
Number of subjects: 1222

Group type: COMPARATOR
Intervention: Relaxation group (relaxation methods and Mindfulness)
Number of subjects: 1222

Group type: COMPARATOR
Intervention: Care as usual group (ordinary antenatal care)
Number of subjects: 1222
Study: 21336094

Group type: EXPERIMENTAL
Intervention: E-MA-H low dose (HLD)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: E-MA-H high dose (HHD)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: E-MA-HP (HP)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 147
Study: 19859560

Group type: EXPERIMENTAL
Intervention: RTS,S/AS01(E)
Number of subjects: 180

Group type: COMPARATOR
Intervention: RTS,S/AS02(D)
Number of subjects: 180
Study: 16675365

Group type: EXPERIMENTAL
Intervention: Experimental intervention by social workers
Number of subjects: 194

Group type: COMPARATOR
Intervention: General practitioners' usual care
Number of subjects: 194
Study: 15249511

Group type: EXPERIMENTAL
Intervention: High-AGE diet (HAGE)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Low-AGE diet (LAGE)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Native LDL
Number of subjects: 24
Study: 11421839

Group type: EXPERIMENTAL
Intervention: 15 mg hyperbaric bupivacaine injected through a 24G Sprotte needle, sitting for 1 min before supine position
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 15 mg hyperbaric bupivacaine injected through a 27G Whitacre needle, sitting for 1 min before supine position
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 15 mg hyperbaric bupivacaine injected through a 24G Sprotte needle, sitting for 4 min before supine position
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 15 mg hyperbaric bupivacaine injected through a 27G Whitacre needle, sitting for 4 min before supine position
Number of subjects: 60
Study: 9269605

Group type: EXPERIMENTAL
Intervention: 0.3% ciprofloxacin
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: 0.3% ofloxacin
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: 0.3% norfloxacin
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: 0.3% ciprofloxacin (short-term)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: 0.3% ofloxacin (short-term)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: 0.3% norfloxacin (short-term)
Number of subjects: 63
Study: 8507053

Group type: EXPERIMENTAL
Intervention: Cystography for any degree of hematuria or diagnosis of pelvic fracture
Number of subjects: 26

Group type: COMPARATOR
Intervention: Cystography only for the presence of gross hematuria
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Cystography for gross hematuria
Number of subjects: 26
Study: 2939715

Group type: EXPERIMENTAL
Intervention: Diclofenac (50 to 75 mg daily, or up to 150 mg per day for longer-term use)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diclofenac
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29848412

Group type: EXPERIMENTAL
Intervention: Structured exercise programme (4-month moderate- to high-intensity), supervised in groups, with support for unsupervised activity thereafter.
Number of subjects: 494

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 494
Study: 27846170

Group type: EXPERIMENTAL
Intervention: SILS‐TEP after previous inguinal hernia repair
Number of subjects: 372

Group type: COMPARATOR
Intervention: Control group (standard procedure)
Number of subjects: 372
Study: 24846621

Group type: EXPERIMENTAL
Intervention: 12 coaching calls
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: 24 coaching calls
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: Reports sent to primary care physician (Yes)
Number of subjects: 560

Group type: COMPARATOR
Intervention: Reports sent to primary care physician (No)
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: Text messaging (Yes)
Number of subjects: 560

Group type: COMPARATOR
Intervention: Text messaging (No)
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: Meal replacement recommendations (Yes)
Number of subjects: 560

Group type: COMPARATOR
Intervention: Meal replacement recommendations (No)
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: Training of a participant's self‐selected support buddy (Yes)
Number of subjects: 560

Group type: COMPARATOR
Intervention: Training of a participant's self‐selected support buddy (No)
Number of subjects: 560
Study: 21837478

Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise for 6 months
Number of subjects: 348
Study: 20231232

Group type: EXPERIMENTAL
Intervention: Lenient rate-control strategy (resting heart rate <110 bpm)
Number of subjects: 614

Group type: COMPARATOR
Intervention: Strict rate-control strategy (resting heart rate <80 bpm and heart rate during moderate exercise <110 bpm)
Number of subjects: 614

Group type: EXPERIMENTAL
Intervention: Lenient rate-control strategy
Number of subjects: 614
Study: 18802363

Group type: EXPERIMENTAL
Intervention: Cholecalciferol 5,000 IU/week
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Cholecalciferol 20,000 IU/week
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 87
Study: 16122653

Group type: EXPERIMENTAL
Intervention: Retromolar grafts
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Anterior pelvic grafts
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Posterior pelvic grafts
Number of subjects: 57
Study: 14534520

Group type: EXPERIMENTAL
Intervention: 600 mg rifampin
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 11214778

Group type: EXPERIMENTAL
Intervention: Grapefruit juice
Number of subjects: 9

Group type: COMPARATOR
Intervention: Orange juice (control)
Number of subjects: 9
Study: 8895942

Group type: EXPERIMENTAL
Intervention: Levomethadone maintenance therapy
Number of subjects: 42

Group type: COMPARATOR
Intervention: Drug-free placebo control group
Number of subjects: 42
Study: 1999634

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 24

Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 24
Study: 6375799

Group type: EXPERIMENTAL
Intervention: Intravenous prostaglandin E1 (PGE1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 30198318

Group type: EXPERIMENTAL
Intervention: Ivabradine
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Pyridostigmine
Number of subjects: 21
Study: 30382877

Group type: EXPERIMENTAL
Intervention: Cognitive Bias Modification (CBM) training
Number of subjects: 300

Group type: COMPARATOR
Intervention: Sham training (Control)
Number of subjects: 300
Study: 27251956

Group type: EXPERIMENTAL
Intervention: Group L (levobupivacaine and fentanyl)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Epidural saline (Group S)
Number of subjects: 60
Study: 24706299

Group type: EXPERIMENTAL
Intervention: Montelukast sodium
Number of subjects: 595
Study: 21342456

Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplement (50 g, 264 kcal)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplement (25 g, 130 kcal)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Corn-soy flour (71 g, 282 kcal)
Number of subjects: 163
Study: 19967459

Group type: EXPERIMENTAL
Intervention: False-negative sentinel lymph node biopsy (FN SLN)
Number of subjects: 2451

Group type: EXPERIMENTAL
Intervention: True-positive sentinel lymph node biopsy (TP SLN)
Number of subjects: 2451

Group type: EXPERIMENTAL
Intervention: True-negative sentinel lymph node biopsy (TN SLN)
Number of subjects: 2451

Group type: EXPERIMENTAL
Intervention: Overall survival in TN group
Number of subjects: 2451

Group type: EXPERIMENTAL
Intervention: Overall survival in TP group
Number of subjects: 2451

Group type: EXPERIMENTAL
Intervention: Overall survival in FN group
Number of subjects: 2451

Group type: COMPARATOR
Intervention: Comparison of overall survival between TP and FN groups
Number of subjects: 2451
Study: 17336026

Group type: EXPERIMENTAL
Intervention: Interactive Voice Response (IVR)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 99
Study: 15746824

Group type: EXPERIMENTAL
Intervention: Intervention group attended a 40‐hour educational course over a 4‐week period
Number of subjects: 337

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 337
Study: 12975259

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/d
Number of subjects: 2402

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2402
Study: 10648308

Group type: EXPERIMENTAL
Intervention: Forced-air warming (FAW)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Circulating water mattress
Number of subjects: 149
Study: 8695926

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy protocol of six days
Number of subjects: 39

Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy protocol of one day
Number of subjects: 39
Study: 1803218

Group type: EXPERIMENTAL
Intervention: Hypertext browsing with computer assistance
Number of subjects: 21

Group type: COMPARATOR
Intervention: Traditional lectures
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Hypertext browsing
Number of subjects: 21
Study: 6196073

Group type: EXPERIMENTAL
Intervention: Bendrofluazide (thiazide treatment)
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Bendrofluazide (long term treatment)
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Bendrofluazide with potassium supplements (long term treatment)
Number of subjects: 324

Group type: COMPARATOR
Intervention: Placebo (long term treatment)
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Both studies pooled data
Number of subjects: 324
Study: 30688974

Group type: EXPERIMENTAL
Intervention: Endovascular thrombectomy plus medical management
Number of subjects: 182

Group type: COMPARATOR
Intervention: Medical management alone
Number of subjects: 182
Study: 28129353

Group type: EXPERIMENTAL
Intervention: Heat and Moisture Exchanger (HME)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Thermal Insulation (TI) and HME (TIHME)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control (no TI, no HME)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Thermal Insulation (TI)
Number of subjects: 41
Study: 25600444

Group type: EXPERIMENTAL
Intervention: 200 µg misoprostol
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (vitamin B6)
Number of subjects: 80
Study: 24307819

Group type: EXPERIMENTAL
Intervention: Video intervention group
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Verbal education group
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study: 21403978

Group type: EXPERIMENTAL
Intervention: H. persicum extract (500 mg/day) + atorvastatin (10 mg/day) for 8 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Atorvastatin (20 mg/day) for 8 weeks
Number of subjects: 100
Study: 19564812

Group type: EXPERIMENTAL
Intervention: Inactivated virosomal‐adjuvanted subunit influenza vaccine (n = 90)
Number of subjects: 180

Group type: COMPARATOR
Intervention: No treatment (n = 90)
Number of subjects: 180
Study: 17127441

Group type: EXPERIMENTAL
Intervention: Antioxidants
Number of subjects: 0
Study: 15309549

Group type: EXPERIMENTAL
Intervention: Boys (17.6 (5.8) s)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Girls (21.9 (8.2) s)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Girls (11.8 (5.5)%)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Boys (8.9 (3.7)%)
Number of subjects: 48
Study: 11507355

Group type: EXPERIMENTAL
Intervention: amoxycillin 1 g bid, metronidazole 500 mg bid, bismuth sub‐citrate 240 mg bid and ranitidine 300 mg bid for 1 week
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: triple therapy without ranitidine for 2 weeks
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: triple therapy plus ranitidine 300 mg bid for 2 weeks
Number of subjects: 240
Study: 9513613

Group type: EXPERIMENTAL
Intervention: Oral 17 beta estradiol 2 mg per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transdermal 17 beta estradiol 50 micrograms per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conjugated estrogens 0.625 mg per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 17 beta estradiol gel 1.5 micrograms per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Estrogen replacement therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Delayed estrogen replacement therapy (at 65 years of age)
Number of subjects: 0
Study: 8498533

Group type: EXPERIMENTAL
Intervention: Bromocriptine (BRC) 1.25 mg per os
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 3591727

Group type: EXPERIMENTAL
Intervention: Aquabiosorb soft elastic gelatin (SEG) capsule
Number of subjects: 12

Group type: COMPARATOR
Intervention: modified standard‐SEG capsule
Number of subjects: 12

Group type: COMPARATOR
Intervention: commercial tablet
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: SEG formulation
Number of subjects: 12
Study: 28272972

Group type: EXPERIMENTAL
Intervention: Solution‐Focused Coaching in pediatric rehabilitation (SFC‐Peds)
Number of subjects: 5
Study: 26638119

Group type: EXPERIMENTAL
Intervention: Memantine (10 mg/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 24892199

Group type: EXPERIMENTAL
Intervention: Virtual body swapping through mental rehearsal
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (watching the virtual body swapping training video clip)
Number of subjects: 10
Study: 22219334

Group type: EXPERIMENTAL
Intervention: Intravenous colloid volume loading (11 ml kg⁻¹) during heat stress
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Lower-body negative pressure (LBNP) while heat stressed
Number of subjects: 7

Group type: COMPARATOR
Intervention: Lower-body negative pressure (LBNP) while normothermic
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Volume loading during heat stress
Number of subjects: 7
Study: 20303444

Group type: EXPERIMENTAL
Intervention: Booster dose of DTaP‐HBV‐IPV/Hib at 12 to 23 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neonatal aP priming
Number of subjects: 0
Study: 18620121

Group type: EXPERIMENTAL
Intervention: Denoised CT images using Aujol's mathematic partial differential equation algorithm
Number of subjects: 71

Group type: COMPARATOR
Intervention: Original CT images
Number of subjects: 71
Study: 17012885

Group type: EXPERIMENTAL
Intervention: Active specific immunotherapy with autologous tumor cell vaccines
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 14614670

Group type: EXPERIMENTAL
Intervention: Intravenous azithromycin (500 mg/day) for 2-7 days, followed by oral azithromycin (1500 mg over 3 or 5 days)
Number of subjects: 25
Study: 10908823

Group type: EXPERIMENTAL
Intervention: Controlled-release metoclopramide 40 mg every 12 hours
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 8694208

Group type: EXPERIMENTAL
Intervention: 1% propofol infusion at 0.1 ml.kg‐1.h‐1 for 24 h after surgery
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intralipid infusion at 0.1 ml.kg‐1.h‐1 for 24 h after surgery (Control)
Number of subjects: 50
Study: 1424648

Group type: EXPERIMENTAL
Intervention: Unpreserved carboxymethylcellulose (CMC) artificial tears
Number of subjects: 56

Group type: COMPARATOR
Intervention: Preserved hydroxypropylmethylcellulose (HMC) artificial tears
Number of subjects: 56
Study: 4070323

Group type: EXPERIMENTAL
Intervention: 200 mg pivmecillinam plus 250 mg pivampicillin given twice daily
Number of subjects: 350

Group type: COMPARATOR
Intervention: 250 mg amoxycillin given 3-times daily
Number of subjects: 350
Study: 31906751

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1 μg/kg + 0.25 mcg/kg/h (group D1)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1 μg/kg + 0.5 mcg/kg/h (group D2)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1 μg/kg + 1 mcg/kg/h (group D3)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 100
Study: 30485853

Group type: EXPERIMENTAL
Intervention: Intensive statin (atorvastatin 60 mg/day, adjusted to 20 mg/day after 7 days)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control (atorvastatin 20 mg/day)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Intensive statin
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control
Number of subjects: 117
Study: 28302075

Group type: EXPERIMENTAL
Intervention: Zinc (60 mg) administration
Number of subjects: 54
Study: 26211002

Group type: COMPARATOR
Intervention: Body acupuncture (Group A)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Sa-am acupuncture (Group B)
Number of subjects: 150
Study: 24461665

Group type: EXPERIMENTAL
Intervention: Late parenteral nutrition (PN)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Early parenteral nutrition (PN)
Number of subjects: 600
Study: 21118161

Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 294

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 294

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 294
Study: 18770084

Group type: EXPERIMENTAL
Intervention: Contingency management interventions with religious activities (engagers n = 34)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Contingency management interventions without religious activities (non-engagers n = 150)
Number of subjects: 184
Study: 16176203

Group type: EXPERIMENTAL
Intervention: Hyperglycaemia (blood glucose level at 16 mmol/l for 3 hours)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Normoglycaemia (blood glucose level at 5 mmol/l for 3 hours)
Number of subjects: 7
Study: 12591750

Group type: EXPERIMENTAL
Intervention: ivabradine 5 mg BID
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: ivabradine 10 mg BID
Number of subjects: 360

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 360
Study: 10536326

Group type: EXPERIMENTAL
Intervention: Mini-detachable snare ligation
Number of subjects: 103

Group type: COMPARATOR
Intervention: Multiple band ligation
Number of subjects: 103
Study: 8678158

Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 gel (4 mg, 2 applications 4 hours apart)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Oxytocin (10 hours, 2 mU/min)
Number of subjects: 200
Study: 1676302

Group type: COMPARATOR
Intervention: Drainage
Number of subjects: 100

Group type: COMPARATOR
Intervention: No Drainage
Number of subjects: 100
Study: 6352601

Group type: EXPERIMENTAL
Intervention: Azlocillin at 8 g/day
Number of subjects: 79

Group type: COMPARATOR
Intervention: Ticarcillin at 12 g/day
Number of subjects: 79
Study: 30896645

Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Endurance-strength training
Number of subjects: 38
Study: 28649868

Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitisation and Reprocessing (EMDR) intervention, Recent Traumatic Episode Protocol (R-TEP) provided within three months of the traumatic event.
Number of subjects: 529

Group type: COMPARATOR
Intervention: Control group analogue (waitlist-like control group)
Number of subjects: 529
Study: 27231116

Group type: EXPERIMENTAL
Intervention: Customized insoles with an added strip of the same material at the site of greatest plantar pressure (n=14)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Ethylvinylacetate insoles (Podaly®) that were individually heat molded and heat glued (n=13)
Number of subjects: 29
Study: 24703486

Group type: EXPERIMENTAL
Intervention: Physiologic replacement-dose recombinant human leptin (metreleptin)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Metreleptin
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Leptin treatment in vitro
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 22691378

Group type: EXPERIMENTAL
Intervention: Vicryl Plus sutures
Number of subjects: 328

Group type: COMPARATOR
Intervention: Conventional Vicryl sutures
Number of subjects: 328
Study: 19034587

Group type: EXPERIMENTAL
Intervention: Hiatal hernia (HH) group
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (NHH)
Number of subjects: 48
Study: 17449890

Group type: EXPERIMENTAL
Intervention: Ultrasound guidance
Number of subjects: 46

Group type: COMPARATOR
Intervention: Nerve stimulator guidance
Number of subjects: 46
Study: 14689162

Group type: EXPERIMENTAL
Intervention: 5 mg diazepam
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 10 mg diazepam
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 20 mg diazepam
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 12494613

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sotalol
Number of subjects: 100
Study: 11368138

Group type: EXPERIMENTAL
Intervention: Uterine artery Doppler screening followed by 100 mg of aspirin daily until the 35th week
Number of subjects: 3317

Group type: COMPARATOR
Intervention: Control group (no Doppler screening and no aspirin treatment)
Number of subjects: 3317
Study: 9432046

Group type: EXPERIMENTAL
Intervention: lenograstim 263 microg/d s.c.
Number of subjects: 90

Group type: COMPARATOR
Intervention: no growth factor
Number of subjects: 90
Study: 8508709

Group type: EXPERIMENTAL
Intervention: Triple therapy (tetracycline hydrochloride 500 mg four times a day for days 0-14 and metronidazole 500 mg three times a day for days 15-28)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Colloidal bismuth subcitrate (120 mg four times a day for 8 weeks)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Triple therapy offered to six patients on bismuth whose ulcers remained unhealed or relapsed early after healing
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Helicobacter pylori-negative patients at 18 months
Number of subjects: 26

Group type: COMPARATOR
Intervention: Helicobacter pylori-positive patients at 18 months
Number of subjects: 26
Study: 3729081

Group type: EXPERIMENTAL
Intervention: Transdermal azatadine maleate TDDS
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Standard oral doses of azatadine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 29783269

Group type: EXPERIMENTAL
Intervention: Intravenous ibuprofen + paracetamol (n = 12)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ibuprofen + placebo (n = 12)
Number of subjects: 24
Study: 27597745

Group type: EXPERIMENTAL
Intervention: Family-based behavioral intervention targeting intake of whole plant foods
Number of subjects: 136
Study: 24523037

Group type: EXPERIMENTAL
Intervention: High-sensitivity C-reactive protein (hsCRP) levels in the top quartile (hsCRP>4.86 mg/L)
Number of subjects: 1244